Identifies themes and clusters of stock movements
Market TodayThemes and Stocks SummaryThematic Stock SearchClick here for daily refresh schedule
MEDS - Trxade Group Inc
$6.00
0.13(2.21%)9:00:00 PM 1/19/2021
Trxade Group, Inc., together with its subsidiaries, owns and operates a business-to-business (B2B) web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; Integra Pharma, LLC; and Other segments. The company operates a web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a web-based pharmaceutical marketplace; InventoryRx.com, a web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, an application, which offers product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics; and Bonum+, a B2B platform to purchase COVID-19 risk assessment and personal protective equipment tools. Trxade Group, Inc. is based in Land O'Lakes, Florida.
Stock Chart
No summary

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
Peers

Related Peers

Stock news

    12/10/2020MEDS
    Trxade Group Announces Strategic Telehealth Partnership with KPH Healthcare Services

    Bonum Health, Trxade Group's Telehealth Subsidiary, Signs Strategic Partnership with Large Retail Pharmacy Chain in Northeastern U.

    12/8/2020MEDS
    Trxade Group Launches Trxade Prime Purchasing Solution to Simplify Prescription Distribution

    Convenient New Purchasing Solution Available in 17 States with More to be Added SoonTAMPA, FL / ACCESSWIRE / December 8, 2020 / Trxade Group, Inc.

    12/3/2020MEDS
    Benzinga's Top Upgrades, Downgrades For December 3, 2020

    Upgrades * For Square Inc (NYSE: SQ), Evercore ISI Group upgraded the previous rating of In-Line to the current rating Outperform. For the third quarter, Square had an EPS of $0.34, compared to year-ago quarter EPS of $0.25. The current stock performance of Square shows a 52-week-high of 215.0 and a 52-week-low of 32.33. Moreover, at the end of the last trading period, the closing price was at $202.06. * For Waddell & Reed Financial Inc (NYSE: WDR), Evercore ISI Group upgraded the previous ra...

    11/24/2020MEDS
    Diamond Equity Research 2020 Virtual Emerging Growth Invitational

    " stated Hunter Diamond, CFA the CEO of Diamond Equity Research.

    11/18/2020MEDS
    TRxADE Group to Present at the Diamond Equity Research Emerging Growth Invitational

    TAMPA, FL, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (MEDS) an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the Diamond Equity Research Emerging Growth Invitational investor conference taking place virtually on December 1, 2020.Suren Ajjarapu, Chief Executive Officer of TRxADE Group, is scheduled to host a virtual presentation to investors, followed by a guided question and answer session as follows:Diamond Equity Resea...

    11/10/2020MEDS
    Return On Capital Employed Overview: Trxade Group

    Trxade Group (NASDAQ: MEDS) posted Q3 earnings of $145.82 thousand, an increase from Q2 of 127.24%. Sales dropped to $6.33 million, a 3.96% decrease between quarters. Trxade Group collected $6.59 million in revenue during Q2, but reported earnings showed a $535.28 thousand loss.What Is Return On Capital Employed? Changes in earnings and sales indicate shifts in Trxade Group's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a h...

    11/10/2020MEDS
    Trxade's stock rockets to pace premarket gainers after Amazon marketing agreement

    Shares of Trxade Group Inc. soared 56% in active trading to pace all of the premarket's gainers Tuesday, after the online platform for pharmaceutical purchases announced a market program agreement with Amazon.com Services. Trading volume spiked up to 4.5 million shares, compared with the full-day average of about 160,000 shares. Under terms of the one-year agreement, Trxade will promote Amazon.com Inc.'s storage lockers (Amazon Lockers) and pick-up program (Amazon Hub Center) to its network of...

    11/10/2020MEDS
    TRxADE Group to Present at the Virtual Fall Investor Summit

    TAMPA, FL, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (MEDS) an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the Virtual Fall Investor Summit, hosted by Investor Summit Group and taking place November 16-18, 2020.Suren Ajjarapu, Chief Executive Officer of TRxADE Group, is scheduled to participate in one-on-one meetings throughout the event and will host a virtual presentation as follows:Virtual Fall Investor SummitDate: ...

    10/27/2020MEDS
    Looking Into Trxade Group's Return On Capital Employed

    Looking at Q3, Trxade Group (NASDAQ: MEDS) earned $145.82 thousand, a 127.24% increase from the preceding quarter. Trxade Group's sales decreased to $6.33 million, a 3.96% change since Q2. In Q2, Trxade Group brought in $6.59 million in sales but lost $535.28 thousand in earnings.Why ROCE Is Significant Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher RO...